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Abstract
In this paper we address the decision of choosing a patient mix for a hospital that leads
to the most beneficial treatment case mix. We illustrate how capacity, case mix and patient
mix decisions are interrelated and how understanding this complex relationship is crucial for
achieving the maximum benefit from the fee-for-service financing system. Although studies
to determine the case mix that is of maximum benefit exist in the literature, the hospital
actions necessary to realize this case mix has seen less attention. We model the hospital as an
M/G/∞ queueing system to evaluate the impact of accepting certain patient types. Using
this queueing model to generate the parameters, an optimization problem is formulated. We
propose two methods for solving the optimization problem. The first is exact but requires
an integer linear programming solver whereas the second is an approximation relying only
on dynamic programming. The model is applied in the department of surgery at a Dutch
hospital. The model determines which patient types result in the desired growth in the
preferred surgical treatment areas. The case study highlights the impact of striving for a
certain case mix without providing a sufficiently balanced supply of resources. In the case
study we show how the desired case mix can be better achieved by investing in certain
capacity.
Keywords: Diagnosis Related Groups, Queueing Theory, Combinatorial Optimization
1 Introduction
In recent years hospital financing has changed from a budget oriented (lump sum) system to
a fee-for-service system [4]. This transformation is intended to enhance accountability and to
motivate hospitals to become more efficient. Diagnosis Related Groups (DRG), a concept which
makes health care services a commodity, is facilitating this change. A DRG describes the whole
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spectrum of activities involved in treating a certain disease or condition. The reimbursement
to the hospital for each DRG treatment is fixed, meaning hospitals that provide the treatment
for lower costs can realize greater profits, hence motivating efficiency. Variants of DRGs were
introduced to achieve the same hospital financing transformation in many countries [19].
As a consequence of fee-for-service financing, hospitals are looking at their DRG case mix and
are evaluating which services should be expanded and which should be discontinued [9,21]. This
is evident in papers [10, 18] that focus on determining which DRGs are of the most benefit to
the hospital. How to realize this DRG case mix has so far not been addressed in the literature.
Furthermore, empirical research indicates that hospitals struggle to make choices that lead to
desired DRG case mixes [1, 2].
To achieve a desired DRG case mix, hospitals must entice certain patients to the hospital.
Patients are usually referred to the hospital by a general practitioner (GP) who evaluates a
patient’s symptoms and decides whether the patient should see a specialist. A referral from a
GP does not specify which DRG treatment is required but rather the symptoms and the most
appropriate modality. The patient then meets a specialist who decides on a treatment plan and
assigns DRGs accordingly. The assigned DRGs may or may not be the ones of greatest benefit,
however it is atypical to turn patients away at this point.
Through advertising and promotion to GPs, hospitals can encourage patients with certain dis-
eases or symptoms to come to their hospital for treatment. However, knowing which symptoms
will lead to the desired DRG case mix is not immediately obvious. Arrivals of patients (char-
acterized by their symptoms) follow a stochastic process, and the required treatment can not
be predicted with certainty. Determining, on the basis of symptoms, which types of patients
(patient mix) to entice to the hospital in order to achieve the desired DRG case mix is the focus
on this paper.
An as example, consider the treatment of Colorectal Cancer. A patient suspected of having Col-
orectal Cancer is referred to a hospital for further testing. The results from the testing could lead
to surgery, chemotherapy, radiotherapy or palliative care for malignant cases, further screening
for benign cases, a referral to a different oncology modality or even no further treatment. Within
each of the treatment scenarios, there are several treatment options (i.e. DRGs) of which some
are more desirable than others. Patient types in this example can be defined in many ways,
but common factors indicating the prevalence of Colorectal Cancer include: personal or family
history of polyps, Colorectal Cancer and/or Bowel Disease, ethnic background, diet, weight,
alcohol use or smoking. Patient types can be further defined by symptoms such as constipa-
tion, diarrhea, blood in stool or jaundice. Patient types have uncertain arrival rates and with
some probability require specific treatments. Thus choosing the best patient types to achieve
the hospital’s desired DRG case mix is not immediately obvious.
Hospitals are also constrained by their capacity levels which presumably relate to their desired
DRG case mix. When capacity is overwhelmed the number of patients in the system increases,
resources become more highly utilized and patient access times become worse. In this paper, to
account for quality degradation due to demand exceeding capacity, we limit the fraction of time
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when demand is allowed to exceed capacity.
In this paper, we determine which patient types to include, such that the maximum benefit
from the DRG case mix is achieved. Once added, patient types cannot be removed in future
periods, as allowing such an “on-again, off-again policy” would create undesired confusion about
the offerings of the hospital. In this way, our problem has similar properties as the Project
Sequencing Problem (PSP). As discussed in the following sections, the PSP determines which
capacity expansion projects to implement in order to fulfill a growing demand for capacity. In
this paper we model the hospital as an M/G/∞ queueing system and formulate an ILP to
exactly solve our problem. Using results from PSP literature we also formulate an approximate
solution.
Statement of contribution: We develop a mathematical model to determine the policy for
accepting new patient types that best matches the desired DRG case mix. To our knowledge it
is the first paper where capacity, DRG case mix and patient mix decisions are accommodated
in a single model facilitating joint decision making.
The paper is organized as follows, Section 2 formally defines and specifies the optimization
problem and the queueing model. Section 3 introduces the PSP and illustrates how it can be used
to approximately solve our problem. In Section 4 a case study is solved and the approximation
evaluated. Throughout the paper the terms DRG and treatment are used interchangeably.
2 Model Description
The problem addressed in this paper is as follows: given that a hospital desires a certain DRG case
mix, which patient types should be accepted (and when) to achieve this case mix while ensuring
capacity restrictions are accounted for. We assume the relative importance of the DRGs are
known and the capacity of the hospital to provide treatments is known for a finite time into the
future. After a patient type is accepted, the number of arrivals of that patient type is modeled as
a stochastic process. Upon arrival, a patient of a given patient type receives treatments according
to some given probability distribution. Our model treats time as continuous and considers a finite
planning horizon.
The formal problem description and a formalization as a combinatorial optimization problem
are presented in Subsection 2.1. The calculation of some of the parameters of this combinatorial
optimization problem is done using a queueing model which is described in Subsection 2.2.
2.1 Combinatorial Optimization Problem
Consider a set of patient types P = {1, 2, . . . , N} and a set of possible treatments T =
{1, 2, . . . ,M}. A patient of type n ∈ P has a probability pn,m of requiring treatment m ∈ T . The
duration of treatment m has cumulative distribution Bm(·) with mean E[Bm]. Let the number
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of arrivals of patient type n in period [0, t) be specified by a given random variable Λn(t) and let
Gm(t) be a given model input which describes the volume of ongoing treatments m for which
the hospital has capacity for at time t. For modelling the problem, we introduce variables Sm(t)
and Dm(t) where Sm(t) is the distribution for the number of patients receiving treatment m at
time t and Dm(t) is the distribution for the number of completed treatments m at time t. Note
that Sm(t) and Dm(t) result from the choice of patient types to be accepted. The desired DRG
case mix is reflected by values wm, which specify the relative importance (or value) of treatment
m.
The problem now is to indicate for each patient type the first moment in time tn that patient
type n is accepted. Note that for all times after tn patient type n must also be accepted. Then the
goal is to determine tn such that the weighted number of treatments (weighted according to wm)
is maximized while ensuring that the number of treatments does not exceed Gm(t) for more than
a fraction ϕm of time. In other words, a hospital with capacity Gm(t) wishes to maximize the
weighted number of treatments they perform, whereby it is acceptable to exceed their capacity for
a certain fraction (1−ϕm) of the time. The value ϕm ∈ (0, 1) is an input parameter reflecting the
hospital’s risk aversion for operating over capacity. A high ϕm value means demand will exceed
capacity frequently (causing, for example, backlogged demand) whereas a low ϕm value means
demand will exceed capacity less frequently (causing, for example, under utilized resources).
Let γ = (t1, t2, . . . , tN ) be a vector of chosen times to accept patient types n and let Ct(γ) be
a reward function measuring the discounted weighted sum of completed treatments for decision
γ. Discounting future costs by e−αt (where α ∈ (0, 1) is the discount factor) to time 0 ensures
that later costs are adequately taken into account. Finding the optimal γ leads to the following
optimization problem,
maximize
∫ T
0
Ct(γ)e−αtdt (P1)
subject to P(Sm(t) ≥ Gm(t)) ≤ ϕm ∀m, t
where
Ct(γ) =
M∑
m=1
E[Dm(t)]wm. (2)
Reward function (2) rewards according to the number of treatments completed, and is moti-
vated by the financing structure at the hospital under study. Other choices are possible and
the choice can be determined by the underlying decision process. Obvious choices include 1)
Ct(γ) =
∑M
m=1 P(Sm(t) ≥ Gm(t)) that rewards according to the fraction of patients that exceed
capacity, 2) Ct(γ) =
∑M
m=1 max {E[Sm(t)−Gm(t)], 0} that rewards according to the expected
amount by which capacity is exceeded and 3) Ct(γ) =
∑M
m=1 E[Sm(t)] which rewards by the ex-
pected number of patients receiving treatment m (assuming Sm(t) is appropriately constrained
in relation to Gm(t)).
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Capacity in our model (Gm(t)) is specified as the volume of ongoing treatments m that the
hospital can accommodate at time t. This implies that the decision of how to allocate available
resource time to treatment types, has already been made (again this follows from the hospital
under study). For example, consider an MRI machine that is available for 2000 minutes per week
for treatments A and B. Assume treatments A and B require 10 and 20 minutes respectively.
One way to divide the 2000 MRI minutes is to allocate 1200 minutes to A and 800 minutes to
B, leading to a volume of GA(t) = 1200/10 = 120 A treatments and GB(t) = 800/20 = 40 B
treatments per week. Because there are numerous ways to distribute the 2000 minutes between
the two treatment types, there are numerous possibilities for GA(t) and GB(t).
Whereas in our model, the decision of how much time to allocate to each treatment type is
already made i.e. we have only a single value of GA(t) (and a single value of GB(t)), in other
settings, it may be desirable to have this resource allocation decision be part of the model. The
presented model can be generalized to accomplish this by defining capacity by the available
treatment time of a resource. In this case the demand for resources can be determined by
multiplying the volume of ongoing treatments Sm(t) by the resource time needed for treatment
m.
To solve (P1), we have to specify how random variables Sm(t) and Dm(t) can be determined for
a given vector of γ. The queueing model defined in Subsection 2.2 is used for this purpose.
2.2 Queueing Model
To calculate the number of patients in treatment (Sm(t)) and the number of patients completing
treatment (Dm(t)), we model the hospital as an M/G/∞ queueing system. Since the population
is a large, and patients get ill independently of each other, it is natural to assume that they
get ill according to a non stationary Poisson process Λ˜n(t). It follows that patients of type n
that arrived to the hospital have a Poisson distribution Λn(t) = Λ˜n(t)Fn(t)qn with mean λn(t)
where qn is the fraction of the population choosing the considered hospital and where Fn(t) = 1
when patient type n is accepted at time t (i.e. tn ≥ t) and Fn(t) = 0 otherwise (without loss of
generality we assume qn = 1).
With probably pn,m [or pn,m(t)] a patient of type n requires treatment m and, thus, the arrival
process of patient type (n,m) is Poisson at rate λn,m(t) = λn(t)pn,m. It can readily be seen
that the number of patients of type n requiring treatment m at time t, Sn,m,tn(t), is distributed
as the number of customers in a non stationary M/G/∞ queue with arrival rate λn,m(t) and
cumulative service time distribution Bm(·) and is given by (see [12]),
P(Sn,m,tn(t) = s) =
e−E[Sn,m,tn (t)](E[Sn,m,tn(t)])s
s!
(3)
where
E[Sn,m,tn(t)] = E[λn,m(t−Be,m)]E[Bm] (4)
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and Be,m is the excess service time with the following cumulative distribution function,
P(Be,m ≤ t) = 1
E[Bm]
∫ t
0
(1−Bm(w)) du. (5)
Observe that Sm(t) =
∑N
n=1 Sn,m,tn(t) is the sum of Poisson random variables and therefore is
Poisson distributed with rate parameter E[Sm(t)] =
∑N
n=1 E[Sn,m,tn(t)]. Like Sm(t), Dm(t) is also
Poisson distributed in a non stationary M/G/∞ queue. In particular, the number of completed
treatments m of patient type n at time t is Poisson with mean E[Dn,m,tn(t)] = E[λn,m(t−Bm)]
and E[Dm(t)] =
∑N
n=1 E[Dn,m,tn(t)].
2.3 Model Characteristics
In this subsection, some observations about infinite server queues and (P1) are explained. These
observation are exploited later when solving the problem. First, entities (patients in our case) are
independent of each other in an infinite server queue. This means, for example, that the amount
of time in the system is not impacted by other patients or the order in which they arrive. It
follows then that the total reward for accepting a new patient type can already be computed at
its acceptance time tn, since these patients are not influenced by other patients, and therefore
not influenced by future decisions. It follows that the reward for adding patient type n at time
tn is,
cn,tn =
M∑
m=1
(∫ T
tn
(
E[Dn,m,tn(t)]e
−αt) dt)wm (6)
and it follows that the objective function from (P1) can be rewritten as,
∫ T
0
Ct(γ)e−αtdt =
N∑
n=1
cn,tne
−α(tn). (7)
The second observation about (P1) is that the constraints are expressions for the ϕm percentiles
of distributions Sm(t) which, when Sm(t) is known, can be evaluated exactly. Let Q[x] represent
the ϕm percentile of distribution x, then
Q[Sm(t)] = sup{s : P(Sm(t) ≥ s) ≤ ϕm} (8)
= sup
{
s :
s∑
k=1
E[Sm(t)]ke−E[Sm(t)]
k!
≤ ϕm
}
(9)
Using this observation the constraints from (P1) can be rewritten as,
subject to Q[Sm(t)] = Q
[
N∑
n=1
Sn,m,tn(t)
]
≤ Gm(t) ∀m, t. (10)
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2.4 Discrete Time Formulation
In this subsection we formulate a discrete time version of (P1) which eliminates the need to
evaluate the integral in its objective function. In the discrete time version of our problem the
continuous time discount equation e−αt is replaced by the equivalent discrete time discount
equation (1/(1 + α))t. Let xn,t be binary decision variables reflecting the first moment in time
when patient type n is accepted. For example, when x3,5 = 1 this means t3 = 5. This leads to
the following integer linear programming (ILP) problem,
maximize
N∑
n=1
T∑
t=0
cn,tnxn,t
(
1
1 + α
)t
(ILP)
subject to
T∑
t=1
xn,t ≤ 1 ∀n (12)
t∑
τ=0
Q
[
N∑
n=1
Sn,m,t−τ (t)
]
xn,t−τ ≤ Gm(t) ∀t, m (13)
xn,t = 0 or 1 ∀n, t.
Constraints (12) ensure that each patient type is accepted only once, while constraints (13)
ensure that the ϕm percentile of demand for treatment m does not exceed Gm(t). For moderate
sized instances the resulting ILP can be solved by commercial ILP solvers like e.g. ILOG CPLEX
Solver.
3 Approximate Solution Approach
In this section we introduce an approximate solution approach (ASA) to our problem which does
not rely on an ILP solver. The approximation exploits the structure of our problem which is
similar to the well studied Project Sequencing Problem (PSP). The PSP can be solved directly
with dynamic programming [3]. As explained in this section, although our problem is similar to
a PSP, it is too general to be solved directly with dynamic programming. To overcome this, we
relax one of the elements of our problem. The relaxation amounts to ignoring the time required
for the newly accepted patient type to populate the system i.e. we ignore the “startup” time.
Formally this is achieved by changing the definition of Sm(t) (See Subsection 3.2). Furthermore
we ignore one of the conditions of the dynamic program necessary to obtain an optimal solution.
We argue that although the solution is not guaranteed to be optimal, within the range of typical
problems, ignoring this assumption has little impact on the solution quality (as illustrated with
numeric examples in Section 4).
The steps in the approximation are as follows: We first relax our problem (by defining Sm(t)
differently) so that it is a PSP. We then apply the dynamic program of [3] to determine the
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sequence in which the patient types should be accepted, i.e. the order not the time. Once this
sequence is known we use the original definition of Sm(t) to iteratively determine the best time
to accept each patient type for the given sequence.
Using the ASA to solve (P1) has three distinct advantages over the ILP approach. The first
being that the ASA relies on dynamic programming and does not require a costly ILP solver.
The second is that the ASA separates the sequencing decision from the timing decision and as
such reduces the complexity. Hence large problem instances that are intractable for the ILP can
be approximated using the ASA. The third advantage is that the PSP is a commonly studied
problem and as such, there are extensions to the dynamic programming approach to solve even
larger problem instances [8]. By formally defining the relationship between our problem and a
PSP, we are able to leverage existing PSP literature to approximately solve very large problem
instances.
This section is organized as follows; in Subsection 3.1 we introduce the PSP and discuss the
dynamic programming solution approach. In Subsection 3.2 we formally introduce the relaxation
of our problem needed for this approach. In Subsection 3.3 we formally define the ASA to our
problem.
3.1 Project Sequencing Problem Review
There is a rich literature on Capacity Expansion problems, as indicated by a number of reviews
[11,15] and books [5,7] spanning multiple decades. Broadly put, the literature concerns choosing
the timing, size and type of capacity expansion needed to fulfill growing demand. Typically,
the objective is to minimize the discounted cost of meeting demand and in doing so, finds the
optimal balance between expanding in large increments to achieve economies of scale, verses
small increments which reduce opportunity (or excess capacity) costs. The literature addresses
many variants of the problem, including finite / infinite planning horizons, linearly /non-linearly
growing demand, deterministic / stochastic demand, and continuous / discrete expansion sizes.
When the choice of expansion projects is limited to a finite set of projects, each with a specified
expansion size, the problem is called a PSP. In this subsection we introduce and review the PSP.
The PSP problem [3,11,17], assumes a finite set of projects R = {1, 2, ..., Y } where each project
y ∈ R has an implementation cost vy and capacity zy. The objective is to determine the im-
plementation times (ty) for each project which minimizes the discounted cost while fulfilling a
pattern of deterministic demand s(t). Formally the problem can be stated as follows,
minimize
∑
y∈R
vye
−αty (14)
subject to
∑
y∈R
zyδy(t) ≥ s(t) ∀ t
where δy(t) = 1 if t ≥ ty (and δy(t) = 0 otherwise).
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Figure 1: The capacity expansion process
To solve (14), Erlenkotter [3] proposes a backward dynamic programming model to determine the
optimal implementation sequence. From this sequence, the optimal implementation time for each
project can be derived. Let X be the state variable where X describes a subset of R representing
the set of implemented projects. Let τ(X) be the latest time when the capacity available from
the implemented projects is greater than the demand, i.e. τ(X) = max{t|∑y∈X zy ≥ s(t)}.
When minimizing excess capacity costs (and when α is positive), it is optimal to add additional
capacity only when existing capacity is exhausted [3, 13, 14, 17]. Figure 1 displays the capacity
expansion process for a one dimensional problem. The following backward dynamic program
determines the optimal sequence for implementing the Y projects,
f(R) = 0
f(X) = min
y/∈X
(
vye
−ατ(X) + f(X ∪ y)
)
, ∀X ⊂ R. (15)
A network representation of (15) can be constructed. Figure 2 displays an example with Y = 3
projects. Finding the shortest path from node ∅ to {1, 2, 3} also gives the optimal sequence in
which the projects should be implemented. Once this sequence is known the time to implement
each project can be determined iteratively using τ(X). When demand is linear, the optimal
policy can be determined without dynamic programming as described in [3]. Other solution
approaches involve integer programming techniques which assume a discrete time scale [16, 20]
and “select jointly the choice of expansion and its timing” [3].
Under the following five assumptions, the Erlenkotter dynamic programming approach finds the
optimal solution:
1) The full capacity is available for use instantaneously upon completion of a project.
2) Project capacity once created has infinite life and does not change over time.
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Figure 2: A network representation of the PSP
3) a) The investment cost is incurred at the time the project is completed. b) The investment
cost does not vary with time.
4) Variable operating and distribution costs are proportional to the amount actually produced
and identical for all projects.
5) Demand must be supplied from current production
3.2 Analogy between our problem and the PSP
By considering each patient type n as a project, our problem is similar to a PSP. Note however,
that we are maximizing the reward, not minimizing capacity investments and that we restrict
this reward by available capacity Gm(t) which is independent of the decision variables. In our
problem Sm(t) depends on the decision variables, thus, when comparing our problem to the PSP,
Q[Sm(t)] is akin to “capacity” and Gm(t) is akin to “demand”.
As discussed below, we can not use Erlenkotter’s dynamic program directly to solve our problem
because it violates assumption 1. To overcome this we modify (relax) our problem. Assumption
2 is also violated, however as discussed below, the impacted of violating this assumption is
minimal. The remaining 3 assumptions are satisfied in our problem.
1) The full capacity is available for use instantaneously upon completion of a project.
This assumption is needed so that the total capacity of a given state can be determined from
the state description. It follows that since the state indicates only the implemented projects
(and not when each project was implemented) that the capacity of a project be independent
on how much time has passed since it was implemented. In other words the capacity must be
determined independently of the time of implementation. Using the definition of Sn,m,tn(t) from
Subsection 2.2, this is not possible because E[Sn,m,tn(t)] depends on tn, see (4).
To overcome this and allow us to use dynamic programming we relax our definition of Sn,m,tn(t).
In our relaxation, we model the number of patients in the system with a steady state M/G/∞
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Figure 3: Illustration of Q[Sn,m,tn(t)] and Q[S′n,m(t)]
queue [6]. In such a queue, the number of patients in the system (S′n,m(t)) is Poisson distributed
with mean E[S′n,m(t)] ≈ λn(t)pn,mE[Bm]. Notice that the definition of E[S′n,m(t)] is independent
of tn. Formally the relaxation that we use in the ASA is as follows,
E[Sn,m,tn(t)] ≈ E[S′n,m(t)] ≈ λn(t)pn,mE[Bm]. (16)
Obviously, in a similar manner S′m(t) denotes the volume of patient receiving treatment m at time
t in this relaxed setting. S′m(t) is Poisson distributed with mean E[S′m(t)] =
∑N
n=1 E[S
′
n,m(t)].
This modification is consistent with other application of the PSP where a project’s capacity
needs to be brought online gradually. Furthermore, when the time between accepting new patient
types is much longer than the mean service time, one would expect that E[Sn,m,tn(t)] will have
converged before the next patient type is accepted and thus this assumption does not impact
the solution. In Figure 3 a sketch of the difference between Q[Sn,m,tn(t)] and Q[S′n,m(t)] is given.
2) Project capacity once created has infinite life and does not change over time.
Since Q[S′n,m(t)] depends on λn(t) which is non stationary in time, this assumption is violated.
However, given that the prevalence of a disease (i.e. the arrival rate for a population of patients)
changes gradually over time, one expects that the impact of violating this assumption is minimal.
3a) The investment cost is incurred at the time the project is completed.
Since the patients are assumed to be independent, the reward can be accounted for at the
moment in time when the patient type is accepted. Although the rewards will take place in the
future, they are known at time tn and can be discounted to time tn.
3b) The investment cost does not vary with time.
This is true in our case since the reward per treatment (wm) does not change over time.
4) Variable operating and distribution cost are proportional to the amount actually produced and
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identical for all projects.
In our problem there are not any variable operating or distribution cost.
5) Demand must be supplied from current production
Our problem is equivalently constrained.
3.3 Dynamic Programming Formulation
In this subsection we first describe how the Erlenkotter approach is used to determine the optimal
sequence to add patient types, given S′n,m(t). We then use the original definition of Sn,m,tn(t)
to determine the times tn and the reward associated with the sequence. These steps together
constitute the ASA.
Sequence in which to add patient types
Let I be a subset of P indicating the patient types n that have already been accepted at a given
moment in time. Our objective is essentially to maximize treatments, and since our discount
rate is positive, it is optimal to accept additional patient types as soon as possible, i.e. at the
first moment in time when a patient type can be added such that Q[S′m(t)] ≤ Gm(t) for all m.
When the set of patient types I is already accepted and when patient type r /∈ I is to be added,
then let this point in time be τ(I ∪ {r}) which is computed as follows,
τ(I ∪ {r}) = inf{t|Q[S′m(t)] ≤ Gm(t), ∀m}. (17)
As explained in Subsection 2.1, the reward for accepting a patient type is the discounted weight
sum of the completed treatments. For the dynamic program to work, we must compute this
reward at the moment in time when the patient type is first accepted. When the set of patient
types I are already accepted and when patient type r is to be added, then the total reward
(discounted to time τ(I ∪ {r})) for adding patient type r is,
cr =
M∑
m=1
(∫ T
τ(I∪{r})
E[Dr,m,τ(I∪{r})(t)]e−αtdt
)
wm. (18)
Using the following backward dynamic program, the sequence in which to add patient types can
be determined,
f(P ) = 0
f(I) = max
r /∈I
(
cre
−ατ(I∪{r}) + f(I ∪ {r})
)
∀i ⊂ P. (19)
Let ϑ = {x1, x2, . . .} be this sequence, where xi is the ith patient type accepted. For example
when ϑ = {6, 2, 4, . . .} then patient type 6 should be accepted first, followed by type 2 and type
4, etc.
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Implementation Times and Reward
Once ϑ is known it is possible to determine the implementation times and the overall reward
associated with this sequence. One option to determine the implementation times and the overall
reward, is to add the following constraints to the ILP formulation of Subsection 2.4,
txk ≤ txk+1, k = 1, 2, . . . , N.
Of course this means the ASA requires an ILP solver and thus, this is not a desirable option.
Alternatively, it is possible for a given sequence to compute the implementation times iteratively
as follows: Start initially with tx1 = tx2 = tx3 = . . . = ∞ and then use (20) to sequentially
calculate tx1, tx2 , . . ..
txz = inf{t|Q[Sm(t)] ≤ Gm(t), ∀m} (20)
Note that in (20) we use Sm(t) as defined in Subsection 2.2 and not the relaxation S′m(t).
If γ′ denotes the set of implementation times associated with sequence ϑ, the reward for the
sequence is,
r(γ′) =
∫ T
0
Ct(γ′)e−αtdt. (21)
In summary we approximate the solution to our problem by relaxing the definition of Sm(t)
according to (16). In this way our problem has a similar structure as a PSP. Then we use the
dynamic programming formulation of Erlenkotter (19) to determine the optimal sequence to add
patient types in the relaxed problem. From this optimal sequence we use the original definition
of Sm(t) and equations (20) and (21) to determine the implementation times (γ′) and the reward
r(γ′). We call this approach the Approximate Solution Approach (ASA).
4 Application and Evaluation of ASA
We have introduced two approaches to solve (P1). The ILP approach (described in Subsec-
tion 2.4) is a discrete time approximation of (P1), although for simplicity and clarity in the
text, we call the ILP solution the optimal solution. The second approach is the ASA which ap-
proximates the solution to (P1). In this section we solve a case study problem and use numeric
problem instances to evaluate and compare the two solutions approaches.
To evaluate the ASA we introduce the problem addressed at the Netherlands Cancer Institute
- Antoni van Leeuwenhoek Hospital (NKI-AVL). Using this problem instance as an initial case
we complete a sensitivity analysis on the parameters that influence the ASA in an effort to
characterize the problem instances where the ASA gives similar results as the ILP approach.
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4.1 Application
NKI-AVL is a comprehensive cancer center in Amsterdam, The Netherlands, which provides hos-
pital care and research. The hospital has 150 inpatient beds and sees about 24,000 new patients
every year. As with many Dutch hospitals, NKI-AVL is eager to expand and provide state-of-
the-art treatments with state-of-the-art equipment. To finance such expansions, managers have
identified which DRGs are of the most value and hence should be the focus of the expansion. To
achieve growth in the desired DRGs, the hospital must decide which patient types are the best
to attract to the hospital and when to do so. In this section we apply our model to support this
decision for the surgical speciality.
Since typically each patient type has a limited number of treatment options, a hospital can
determine which additional patient types to accept by solving a number of subproblems. For
example, historical records for the hospital in this study indicate that there are 37 different
patient types (defined by their cancer diagnosis) and 109 different treatments. However some
patient types have 0% probability of needing certain treatments and as such, it is possible
to divide this 37 by 109 dimension problem into a number of subproblems of much smaller
dimensions. The subproblem solved in this section is called the “surgical specialty” subproblem
as it encompasses all surgical treatments and their corresponding patient types resulting in six
patient types and 34 treatment types. Seven of the 34 treatment types represent over 90% of
the total volume of treatments, thus in the interest of brevity, we only include these seven in
the analysis.
Management of the surgical specialty do not expect new patient types to be added to the hospital,
rather that the volume of existing patient types will increase if/when they try to attract them.
This is essentially the same problem whereby the increased arrival rate of a patient type resulting
from some hospital action, represents a new patient type. Our goal is to determine the time when
this “new patient type” should be accepted. Management also have forecasted estimates of the
amount by which the volume of each patient type will increase, which corresponds to the arrival
rates of the “new patient types”. All data, other than these estimates, comes from the hospital’s
historic records. All the patient types discussed in the remainder of this section represent “new
patient types”.
The ILP was solved using ILOG CPLEX Solver 12.2 and the parameters (generated via the
queueing model) were computed using Microsoft Visual Basic. The dynamic program used in
the ASA was solved with Dijkstra’s algorithm programmed in MatLAB. The parameters for the
ASA were also computed using Microsoft Visual Basic.
4.1.1 Application Data
The fraction of patients of type n that will receive treatment type m is available in Table 1. Note
that since it is possible for a patient to have multiple treatments, the sum of the probabilities
across each row can be greater than 100%. In a similar manner, the sum can be less than 100%
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Table 1: The fraction of patients of type n that receive treatment type m (pn,m)
Treatments (m)
Patient Types (n) 1 2 3 4 5 6 7
1 Lung Cancer 24.8% 0% 57.1% 0% 3.7% 0% 6.7%
2 Lung Cancer (Pleura) 21.2% 0% 53% 0% 7.7% 0% 4.9%
3 Breast Cancer 54.8% 35.9% 0% 7.4% 3.3% 2.8% 0%
4 Colon Cancer 23.6% 0% 46.2% 0% 9.2% 0% 11.5%
5 Colon Cancer (Sigmoid) 32.1% 0% 38.4% 0% 9% 0% 23%
6 Colon Cancer (Rectum) 4% 0% 56% 0% 0% 0% 16%
Table 2: The mean arrival rate (patients / month) for patient type n
Years
n 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
1 2.17 2.51 2.91 3.36 3.89 4.49 5.2 6.01 6.95 8.03 9.28 10.73
2 0.59 0.68 0.79 0.91 1.05 1.22 1.41 1.63 1.88 2.18 2.52 2.91
3 34.3 37.73 41.51 45.66 50.23 55.25 60.77 66.85 73.54 80.89 88.98 97.88
4 4.79 5.54 6.4 7.4 8.55 9.89 11.43 13.22 15.28 17.66 20.42 23.61
5 2.09 2.38 2.72 3.1 3.54 4.03 4.6 5.24 5.97 6.81 7.77 8.85
6 2.39 2.73 3.11 3.55 4.05 4.61 5.26 6 6.84 7.8 8.89 10.14
7 0.74 0.86 0.99 1.15 1.33 1.53 1.77 2.05 2.37 2.74 3.17 3.67
since only 7 of the 34 treatment types are included.
The relative importance of each DRG (wm) relates to the renumeration amount that the hospital
receives for each. The actual values are excluded for proprietary reasons, although they rank as
follows, w7 > w6 > w4 > w3 > w2 > w5 > w1. The forecasted arrival rate (patients / month)
for each patient type n is shown in Table 2.
The mean service time (E[Bm]) for each treatment type m is shown in Table 3. The distributions
have been left out of the text for brevity. The capacity (Gm(t)) to provide treatment type m
over the 11 year planning horizon is shown in Table 4.
For ϕm, several values ranging from 0.9 to 0.1 were considered in order to illustrate the sensitivity
of this parameter. We discretized the problem into monthly periods, meaning a patient type can
only be added at the beginning of the month.
Table 3: The mean service time (E[Bm]) for each treatment type m
Treatments (m)
1 2 3 4 5 6 7
E[Bm] (months) 16.3 11.8 16.7 3.6 7.7 3.0 5.0
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Table 4: The capacity (Gm(t)) to treat patients of type m over the 11 year planning horizon
Years
m 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
1 2004 2204 2424 2546 2673 2807 2947 3094 3249 3411 3582 3761
2 1573 1730 1903 1998 2098 2203 2313 2429 2550 2678 2812 2952
3 409 450 495 519 545 573 601 631 663 696 731 767
4 266 292 322 338 355 372 391 411 431 453 475 499
5 210 231 254 267 280 294 309 325 341 358 376 395
6 89 98 108 113 119 125 131 138 145 152 159 167
7 79 87 96 101 106 111 117 122 129 135 142 149
Table 5: Initial solution to case study (given in months)
t1 t2 t3 t4 t5 t6 Reward
ILP Solution 0 0 53 143 100 112 24,121
4.1.2 Results
Solving (P1) with the above data as input, the optimal reward and timing for accepting the
patient types was determined and is displayed in Table 5. However after comparing the volume
of patients receiving treatment with the available capacity, it was observed that for all treatment
types (other than m = 7), the volume receiving treatment was much less that the capacity. It
followed that treatment type m = 7 was the bottleneck resource and that it was significantly
debilitating to the system. For example, Q[S7(t)] > G7(t) (for all t) whereas the opposite was
true for the 6 other treatment types. To improve on this, we used the model to investigate how
the reward changes as the capacity to provide treatment m = 7 is increased.
We increased the capacity of treatment type m = 7 by 10, 20, 30 and 40% and observed the
corresponding reward. As illustrated in Figure 4, increasing the capacity in this way allows the
reward to increase by more than a factor of 2. Also observable in Figure 4, is that increasing the
capacity by more than 30% does not increase the reward, as a new bottleneck emerges.
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Figure 4: Reward associated with increasing capacity for treatment type m = 7
16
Table 6: Comparison of the ILP and ASA solutions to the Case Study problem instance
t1 t2 t3 t4 t5 t6 Reward
ILP Solution 25 0 53 14 0 3 67,220
ASA Solution 0 0 53 53 0 11 56,529
Figure 4 demonstrates that if additional resources were made available for treatment type m = 7
then the hospital’s reward would increase significantly. The decision is left with management
whether the increase in the reward justifies the additional investment in capacity. Repeating this
process of identifying the bottleneck and deciding whether additional expansions are warranted
can help balance the supply and demand in the hospital. In the same vein the model can be
used to determine the extent to which capacity can be decreased for certain treatment types.
After several iterations of the model, appropriate resource levels were determined and a final
solution was found. The “ILP Solution” row of Table 6 lists the reward and time when each
patient type should be accepted.
Using this information the hospital can develop a strategy for enticing patients to the hospital.
In general we conclude that in the short term (0 to 15 months) the hospital should focus on
attracting patient types 2, 5 and 6. In the medium term (15 to 30 months) the hospital should
focus on patient types 1 and 4. In the long term, patient type 3 should be the focus. That
said, the model can be used to reevaluate this policy in later years, after the level of success in
attracting new patients is known. This of course could result in a new strategy to replace the
current long term strategy.
4.2 Evaluation of Approximate Solution Approach
The analysis of the preceding subsection were completed according to the ILP approach. In
this subsection we use the same case study and compare solutions of the ASA with those from
the ILP approach. Furthermore, we perform a sensitivity analysis on the main parameters that
impact the approximation.
To evaluate the ASA, consider that all model parameters are the same and the only difference be-
tween the ASA and the ILP approach is how we model the volume of patient receiving treatment
(S′m(t) for the ASA and Sm(t) for the ILP approach). Thus to evaluate the ASA, we complete a
sensitivity analysis on the parameters that impact this volume (λn(t) and E[Bm]) and also the
capacity parameter (Gm(t)). For parameters λn(t) and Gm(t) we vary the rate of change from t
to t+1 and for E[Bm] we simply vary its value. More than 20 problem instances were evaluated
to draw conclusions on the validity of the ASA. We use the following four instances to illustrate
these conclusions.
Problem Instance 1: This is the case study described above. Table 6 compare the solutions to
the case study found by both approaches.
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Table 7: Comparison of the ILP and ASA solutions to problem instance 2
t1 t2 t3 t4 t5 t6 Reward
ILP Solution 12 0 126 30 0 5 52,616
ASA Solution 30 0 126 30 0 5 50,306
Table 8: Comparison of the ILP and ASA solutions to problem instance 3
t1 t2 t3 t4 t5 t6 Reward
ILP Solution 37 0 79 34 16 26 20,792
ASA Solution 22 16 79 33 16 37 19,954
Problem Instance 2: In this problem instance we increase the rate by which function λn(t)
changes from one period to the next. We make the rate the same for all patient types such that
λn(t)/λn(t+12) = 15% for all n, meaning each patient population is increasing by 15% per year.
This problem reflects a situation where the prevalence of certain diseases is increasing rapidly.
Results for this problem instance are given in Table 7.
Problem Instance 3: In this problem instance we decrease the rate by which function Gm(t)
changes from one period to the next. We make the rate the same for all treatment types such
that Gm(t)/Gm(t + 12) = 5% for all m. As such, this problem instance represents a hospital
with modest growth ambitions. Results for this problem instance are given in Table 8.
Problem Instance 4: The mean time to complete a treatment (E[Bm]) is set to 3.5 months in
this example. Results for this problem instance are given in Table 9.
When comparing the performance of the ASA for the 4 problem instances above, it performed
the worst in the case study. In all other instances, the ASA reward was within 6% of optimal
(in the case study the ASA reward was within 16% of optimal). This leads to the conclusion
that good solutions can be found with the ASA. In particular, this is true when E[Bm] is small
and when the rates of change of λn(t) and Gm(t) are homogeneous with respect to patient and
treatment types.
However, not only is the objective function value important, but also the structure of the solution
indicating when patient types should be accepted. For our instances this structure is similar in
both approaches. This is particularly true in the short term (i.e. the first two or three patient
types which should be accepted). In this way the ASA can be used to solve the short term plan,
and then at (or near) the end of the term, the problem can be reevaluated with up-to-date
parameters. As such, in the absence of an advanced ILP solver, the ASA approach can be used
as the kernel of a control policy.
Table 9: Comparison of the ILP and ASA solutions to problem instance 4
t1 t2 t3 t4 t5 t6 Reward
ILP Solution 18 0 55 26 0 16 62,704
ASA Solution 55 0 55 24 0 16 60,225
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Furthermore, like the ILP approach, the ASA can be used to identify the bottleneck resource.
For example, analyzing the case study with the ASA leads to the same conclusions about the
bottleneck resource. The increase in the reward that results from adding capacity to treatment
type m = 7 is significant (and much greater than the increase in reward which results from the
using the optimal versus approximate solution). Hence improvements with respect to balancing
capacity further justify the ASA.
5 Discussion
In this paper we illustrate how capacity, case mix and patient mix decisions are interrelated.
Understanding the complex relationships existing between these factors is crucial for achieving
the maximum benefit from the DRG fee-for-service financing system. The case study highlights
the impact of striving for a certain case mix without providing a balanced supply of resources.
The presented model can be extended to situations where the hospital has different motivators
but still wishes to strike a balance between capacity, case mix and patient mix. In the remainder
of this section we discuss three such situations.
Consider a hospital which wishes to maximize utilization of its resources instead of maximiz-
ing the number of completed treatments. By changing the reward function to account for the
difference between Sm(t) and Gm(t) such a motivator can be accommodated.
Although this work has been applied in a hospital with fee-for-service financing, the model also
has merit for health care system operating with a lump-sum budget. In such systems, hospitals
typically work together with more complicated cases being treated in larger general hospitals
and less complicated cases being treated in smaller regional hospitals. The decision on whether
or not to treat a certain patient type at a certain hospital is similar to the problem addressed
in this paper.
The third situation considers ongoing changes in the Dutch health care system where the renu-
meration of some DRGs can be negotiated. In this case hospitals may strive for a certain quota
of treatments, as exceeding it (or not meeting it) may result in penalties. To incorporate this,
the described model can be used by making the reward depend on completed treatments per
year. Furthermore, because overproduction will be penalized, the capacity constraints can be
removed and the capacity levels required to meet treatment quotas become a model output.
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